Fatty liver may alter Kids' response to cholesterol meds
NCT ID NCT04903223
Summary
This study aims to understand how fat in the liver affects how children and teenagers process and respond to a common cholesterol-lowering drug called rosuvastatin. Researchers will enroll 50 participants aged 8-21 with high cholesterol and a specific genetic background. They will use MRI scans to measure liver fat and see if it changes the drug's effectiveness or risk of side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLESTEROL; LIPIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Mercy Hospital
RECRUITINGKansas City, Missouri, 64108, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.